Day One Biopharmaceuticals Inc (DAWN)
16.89
-0.28
(-1.63%)
USD |
NASDAQ |
May 06, 13:28
Day One Biopharmaceuticals Free Cash Flow (Quarterly): -41.38M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -41.38M |
| September 30, 2023 | -40.10M |
| June 30, 2023 | -42.58M |
| March 31, 2023 | -26.01M |
| December 31, 2022 | -35.31M |
| September 30, 2022 | -23.22M |
| June 30, 2022 | -29.79M |
| March 31, 2022 | -21.58M |
| Date | Value |
|---|---|
| December 31, 2021 | -13.17M |
| September 30, 2021 | -12.22M |
| June 30, 2021 | -13.41M |
| March 31, 2021 | -17.74M |
| December 31, 2020 | -5.937M |
| September 30, 2020 | -3.578M |
| June 30, 2020 | -1.893M |
| March 31, 2020 | -2.173M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-42.58M
Minimum
Jun 2023
-1.893M
Maximum
Jun 2020
-20.63M
Average
-19.66M
Median
Free Cash Flow (Quarterly) Benchmarks
| Revolution Medicines Inc | -122.88M |
| Zentalis Pharmaceuticals Inc | -40.77M |
| Perspective Therapeutics Inc | -9.097M |
| Electromed Inc | 3.384M |
| Xtant Medical Holdings Inc | -1.278M |